← Back
Data updated: Mar 10, 2026
BOSTAL
Metabolic
BOSTAL is a generic drug manufacturer focused on Metabolic.
2011
Since
3
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FENOFIBRATE 2026-01-21
FENOFIBRATE 2025-08-28
Labeling
FENOFIBRATE 2025-08-21
Labeling
FENOFIBRATE 2025-08-21
Labeling
FENOFIBRATE 2025-08-21
Labeling
FENOFIBRATE 2025-08-07
Manufacturing (CMC)
METHOCARBAMOL 2025-04-08
Labeling
SOLIFENACIN SUCCINATE 2025-03-04
SOLIFENACIN SUCCINATE 2025-02-04
Labeling
FENOFIBRATE 2024-11-13
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 2011-10-21
- Latest
- 2025-08-07
- Applications
- 4